The FAQs of Filming

Hints and Tips on how to produce good quality vide

Reply to: Punctuated transgression (?): Comment on Oliver, T.S.N., Donaldson, P., Sharples, C., Roach, M., and Woodroffe, C.D. Punctuated progradation of the Seven Mile Beach Holocene barrier system, southeastern Tasmania

Our interpretation of the depositional history of the prograded barrier at Seven Mile Beach in Tasmania, described in Oliver et al. (2017a), was based on the morphology of ridges apparent in the LiDAR-based digital elevation data and a sample of 14 optically-stimulated luminescence (OSL) ages. Dougherty (2018) has identified gaps in the chronology and speculated that progradation may have occurred as sea level fell from a mid-Holocene highstand inappropriately applying sea-level curves from mainland Australia. Despite a highstand being inferred by early research in Tasmania, glacio-isostatic modelling and recent sea-level studies adopted a prevailing view that excluded a highstand. Our observations led us to question this prevailing view and to suggest that it might be appropriate to reopen the debate on Holocene sea-level change in Tasmania. We welcome the renewed interest in the chronology and sea-level history of this prograded barrier, and look forward to further clarification based on new evidence. The site may have the potential to become one of the more continuous and better-constrained sea-level records in southern Australia

Optimising TGLF for a Q=10 Burning Spherical Tokamak

TGLF transport model predictions have been assessed in the vicinity of a theoretical high β burning plasma spherical tokamak at Q=10. Linear micro-stability calculations from TGLF have been compared on a surface at mid-radius with the gyrokinetic code GS2. Differences between TGLF and GS2 spectra can be characterised by the RMS difference in growth rates, σγ. We find considerable improvement in the quality of TGLF growth rate spectrum can be achieved by increasing the number of parallel basis functions and by tuning the TGLF parameter used in the model for trapped particles, θtrap

Gaussian Process Regression models for the properties of micro-tearing modes in spherical tokamak

Spherical tokamaks (STs) have many desirable features that make them an attractive choice for a future fusion power plant. Power plant viability is intrinsically related to plasma heat and particle confinement and this is often determined by the level of micro-instability driven turbulence. Accurate calculation of the properties of turbulent micro-instabilities is therefore critical for tokamak design, however, the evaluation of these properties is computationally expensive. The considerable number of geometric and thermodynamic parameters and the high resolutions required to accurately resolve these instabilities makes repeated use of direct numerical simulations in integrated modelling workflows extremely computationally challenging and creates the need for fast, accurate, reduced-order models. This paper outlines the development of a data-driven reduced-order model, often termed a {\it surrogate model} for the properties of micro-tearing modes (MTMs) across a spherical tokamak reactor-relevant parameter space utilising Gaussian Process Regression (GPR) and classification; techniques from machine learning. These two components are used in an active learning loop to maximise the efficiency of data acquisition thus minimising computational cost. The high-fidelity gyrokinetic code GS2 is used to calculate the linear properties of the MTMs: the mode growth rate, frequency and normalised electron heat flux; core components of a quasi-linear transport model. Five-fold cross-validation and direct validation on unseen data is used to ascertain the performance of the resulting surrogate models

A process model of dynamic capability development: Evidence from the Chinese manufacturing sector

Based on longitudinal case studies of manufacturing strategy and implementation at two Chinese manufacturing firms, this paper investigates how these firms develop, manage and deploy dynamic capabilities to renew their resource bases in order to respond to the operational challenges associated with radical technological development. Our analysis suggests that dynamic capability development is not simply about renewing one specific type of capability, but rather, it is a meta-capability to learn how to repeatedly renew the firm’s overall capability set as a fully integrated package. We further highlight the importance of looking beyond the property of the firm to understand the network level of capability development, including the capabilities of the firm’s partners. This is particularly salient in the context of smart manufacturing where a high level of connectivity among a broader network of partners is required to reap the benefits generated by new technological advances. Our findings provide an important contribution to our knowledge of dynamic capability development in emerging economies in the era of digitalized manufacturing

Management of patients with advanced prostate cancer : the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

BACKGROUND: In advanced prostate cancer (APC), successful drug development as well as advances in imaging and molecular characterisation have resulted in multiple areas where there is lack of evidence or low level of evidence. The Advanced Prostate Cancer Consensus Conference (APCCC) 2017 addressed some of these topics. OBJECTIVE: To present the report of APCCC 2017. DESIGN, SETTING, AND PARTICIPANTS: Ten important areas of controversy in APC management were identified: high-risk localised and locally advanced prostate cancer; "oligometastatic" prostate cancer; castration-naïve and castration-resistant prostate cancer; the role of imaging in APC; osteoclast-targeted therapy; molecular characterisation of blood and tissue; genetic counselling/testing; side effects of systemic treatment(s); global access to prostate cancer drugs. A panel of 60 international prostate cancer experts developed the program and the consensus questions. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The panel voted publicly but anonymously on 150 predefined questions, which have been developed following a modified Delphi process. RESULTS AND LIMITATIONS: Voting is based on panellist opinion, and thus is not based on a standard literature review or meta-analysis. The outcomes of the voting had varying degrees of support, as reflected in the wording of this article, as well as in the detailed voting results recorded in Supplementary data. CONCLUSIONS: The presented expert voting results can be used for support in areas of management of men with APC where there is no high-level evidence, but individualised treatment decisions should as always be based on all of the data available, including disease extent and location, prior therapies regardless of type, host factors including comorbidities, as well as patient preferences, current and emerging evidence, and logistical and economic constraints. Inclusion of men with APC in clinical trials should be strongly encouraged. Importantly, APCCC 2017 again identified important areas in need of trials specifically designed to address them. PATIENT SUMMARY: The second Advanced Prostate Cancer Consensus Conference APCCC 2017 did provide a forum for discussion and debates on current treatment options for men with advanced prostate cancer. The aim of the conference is to bring the expertise of world experts to care givers around the world who see less patients with prostate cancer. The conference concluded with a discussion and voting of the expert panel on predefined consensus questions, targeting areas of primary clinical relevance. The results of these expert opinion votes are embedded in the clinical context of current treatment of men with advanced prostate cancer and provide a practical guide to clinicians to assist in the discussions with men with prostate cancer as part of a shared and multidisciplinary decision-making process

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

Tumour genomic and microenvironmental heterogeneity as integrated predictors for prostate cancer recurrence: a retrospective study

Clinical prognostic groupings for localised prostate cancers are imprecise, with 30–50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We aimed to test combined genomic and microenvironmental indices in prostate cancer to improve risk stratification and complement clinical prognostic factors

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts